Method to enhance the immunogenicity of an antigen
AssigneeTorrey Pines Institute for Molecular Studies
InventorCarol O. Cowing
Life of this patent
Estimating the term…
Abstract
The present invention is related to a method for enhancing the immunogenicity of an antigen in a mammal by introducing into the mammal an antigen or a portion thereof and administering to the mammal a treatment that increases antigen presentation in a lymphoid organ.
Claims57
A method for vaccinating a mammal against an antigen, comprising:
- introducing into the mammal an effective dose of the antigen or an epitope(s) thereof;
- and
- administering to the mammal a topical treatment in an amount sufficient to increase the number of antigen-bearing dendritic cells in a lymphoid organ,
- wherein introducing the antigen and administering the treatment are performed independently in any order.
A method of immunization against an antigen in a mammal, comprising:
- introducing into the mammal an expression vector adapted to induce the prolonged expression of the antigen or epitope thereof;
- and
- administering a topical treatment to the mammal during a period when the antigen is being expressed, wherein the topical treatment is administered in an amount sufficient to increase the number of antigen-bearing dendritic cells in a draining lymphoid organ.
A method for vaccinating a mammal against an antigen, comprising:
- injecting into the mammal an effective dose of the antigen or an epitope(s) thereof;
- and
- administering to the mammal a topical treatment in an amount sufficient to increase the number of antigen-bearing dendritic cells in a draining lymphoid organ,
- wherein the topical treatment comprises a lipophilic molecule with a molecular weight of <500 daltons.
A method for enhancing an immune response in a mammal against an endogenous antigen, comprising repeated topical application to the mammal of a lipophilic compound having a molecular weight <500 daltons, wherein the lipophilic compound is applied in an amount sufficient to increase the number of antigen-bearing dendritic cells in a lymphoid organ.
A method for vaccinating a mammal against an antigen, comprising:
- delivering to the mammal a nucleic acid vaccine, comprising DNA or RNA encoding the antigen or an epitope(s) thereof;
- and
- administering to the mammal a topical treatment in an amount sufficient to increase the number of antigen-bearing dendritic cells in a lymphoid organ,
- wherein the topical treatment comprises a lipophilic molecule with a molecular weight of <500 daltons.
A method for vaccinating a mammal against an antigen, comprising:
- providing the mammal with an effective dose of the antigen or an epitope(s) thereof;
- and
- administering internally to the mammal a treatment in an amount sufficient to increase the number of antigen-bearing dendritic cells in a lymphoid organ.
Dependencies are inferred from the claim text.